IDEX (IEX) Receiving Somewhat Favorable News Coverage, Study Finds

News stories about IDEX (NYSE:IEX) have been trending somewhat positive this week, according to Accern. The research firm scores the sentiment of press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. IDEX earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave news stories about the industrial products company an impact score of 46.6124052453124 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

IEX traded down $3.86 during trading on Friday, reaching $138.77. 293,282 shares of the company traded hands, compared to its average volume of 283,674. The company has a debt-to-equity ratio of 0.46, a current ratio of 2.78 and a quick ratio of 2.06. The firm has a market cap of $10,620.76, a P/E ratio of 32.20, a price-to-earnings-growth ratio of 2.10 and a beta of 1.20. IDEX has a 12-month low of $91.60 and a 12-month high of $150.72.

How to Become a New Pot Stock Millionaire

IDEX (NYSE:IEX) last posted its earnings results on Monday, January 29th. The industrial products company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.05. The firm had revenue of $585.90 million during the quarter, compared to the consensus estimate of $573.47 million. IDEX had a return on equity of 18.88% and a net margin of 14.74%. The company’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.96 EPS. sell-side analysts anticipate that IDEX will post 5.07 earnings per share for the current year.

A number of brokerages have issued reports on IEX. SunTrust Banks increased their price objective on shares of IDEX to $145.00 in a report on Thursday, February 1st. They noted that the move was a valuation call. UBS began coverage on shares of IDEX in a report on Monday, January 22nd. They set a “neutral” rating for the company. Zacks Investment Research raised shares of IDEX from a “hold” rating to a “buy” rating and set a $162.00 price objective for the company in a report on Friday, February 2nd. Stifel Nicolaus reaffirmed a “hold” rating and set a $132.00 price objective on shares of IDEX in a report on Thursday, December 14th. Finally, Robert W. Baird reaffirmed a “buy” rating and set a $141.00 price objective on shares of IDEX in a report on Friday, December 15th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. IDEX has an average rating of “Hold” and a consensus target price of $137.56.

WARNING: “IDEX (IEX) Receiving Somewhat Favorable News Coverage, Study Finds” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3341910/idex-iex-receiving-somewhat-favorable-news-coverage-study-finds.html.

About IDEX

IDEX Corporation (IDEX) operates an applied solutions business that sells pumps, flow meters and other fluidics systems, and components and engineered products. The Company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST) and Fire & Safety/Diversified Products (FSDP).

Insider Buying and Selling by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Franko Market Capitalization Tops $115,130.00
Franko Market Capitalization Tops $115,130.00
Pluristem Therapeutics  Given a $3.00 Price Target by Maxim Group Analysts
Pluristem Therapeutics Given a $3.00 Price Target by Maxim Group Analysts
Ripio Credit Network  Trading 28.5% Higher  Over Last Week
Ripio Credit Network Trading 28.5% Higher Over Last Week
Triaconta  Price Hits $6.44 on Top Exchanges
Triaconta Price Hits $6.44 on Top Exchanges
Sysco  and Domino’s Pizza  Critical Comparison
Sysco and Domino’s Pizza Critical Comparison
Universal Display  and AVX  Head to Head Comparison
Universal Display and AVX Head to Head Comparison


© 2006-2018 Ticker Report. Google+.